Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer

NCT06220214 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Locally Advanced Breast Cancer
Neoadjuvant Chemotherapy
HER2-positive Breast Cancer
Triple Negative Breast Cancer
TNBC, Triple Negative Breast Cancer

Interventions

DIAGNOSTIC_TEST: CEDM
DIAGNOSTIC_TEST: CEDBT
DRUG: Omnipaque 350mgI/mL Solution for Injection

Sponsor

Alison Stopeck